It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Impaired secretion of an essential blood coagulation factor fibrinogen leads to hepatic fibrinogen storage disease (HFSD), characterized by the presence of fibrinogen-positive inclusion bodies and hypofibrinogenemia. However, the molecular mechanisms underlying the biogenesis of fibrinogen in the endoplasmic reticulum (ER) remain unexplored. Here we uncover a key role of SEL1L-HRD1 complex of ER-associated degradation (ERAD) in the formation of aberrant inclusion bodies, and the biogenesis of nascent fibrinogen protein complex in hepatocytes. Acute or chronic deficiency of SEL1L-HRD1 ERAD in the hepatocytes leads to the formation of hepatocellular inclusion bodies. Proteomics studies followed by biochemical assays reveal fibrinogen as a major component of the inclusion bodies. Mechanistically, we show that the degradation of misfolded endogenous fibrinogen Aα, Bβ, and γ chains by SEL1L-HRD1 ERAD is indispensable for the formation of a functional fibrinogen complex in the ER. Providing clinical relevance of these findings, SEL1L-HRD1 ERAD indeed degrades and thereby attenuates the pathogenicity of two disease-causing fibrinogen γ mutants. Together, this study demonstrates an essential role of SEL1L-HRD1 ERAD in fibrinogen biogenesis and provides insight into the pathogenesis of protein-misfolding diseases.
Fibrinogen, a key blood clotting factor, is produced in the endoplasmic reticulum (ER) of hepatocytes. Here, authors uncover the vital role of ER- associated degradation in preventing fibrinogen aggregation and ensuring its proper biogenesis.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details






1 University of Virginia School of Medicine, Department of Pharmacology, Charlottesville, USA (GRID:grid.27755.32) (ISNI:0000 0000 9136 933X); Wayne State University School of Medicine, Center for Molecular Medicine and Genetics, Detroit, USA (GRID:grid.254444.7) (ISNI:0000 0001 1456 7807)
2 Wayne State University School of Medicine, Center for Molecular Medicine and Genetics, Detroit, USA (GRID:grid.254444.7) (ISNI:0000 0001 1456 7807)
3 University of North Carolina at Chapel Hill, Department of Pathology and Laboratory Medicine, Chapel Hill, USA (GRID:grid.10698.36) (ISNI:0000 0001 2248 3208); University of North Carolina at Chapel Hill, Lineberger Comprehensive Cancer Center, Chapel Hill, USA (GRID:grid.10698.36) (ISNI:0000000122483208); University of North Carolina at Chapel Hill, UNC Blood Research Center, Chapel Hill, USA (GRID:grid.10698.36) (ISNI:0000 0001 2248 3208)
4 University of Michigan Medical School, Department of Molecular & Integrative Physiology, Ann Arbor, USA (GRID:grid.214458.e) (ISNI:0000000086837370)
5 University of Virginia School of Medicine, Department of Molecular Physiology and Biological Physics, Charlottesville, USA (GRID:grid.27755.32) (ISNI:0000 0000 9136 933X)
6 Northwestern University Feinberg School of Medicine, Department of Pathology, Chicago, USA (GRID:grid.16753.36) (ISNI:0000 0001 2299 3507); Temple University, Department of Cardiovascular Sciences and Center for Metabolic Disease Research, Lewis Katz School of Medicine, Philadelphia, USA (GRID:grid.264727.2) (ISNI:0000 0001 2248 3398)
7 Versiti Blood Center of Wisconsin, Blood Research Institute, Milwaukee, USA (GRID:grid.280427.b) (ISNI:0000 0004 0434 015X); Medical College of Wisconsin, Departments of Surgery, Biochemistry, Biomedical Engineering, and Pharmacology and Toxicology, Milwaukee, USA (GRID:grid.30760.32) (ISNI:0000 0001 2111 8460)
8 University of Adelaide, Research Centre for Infectious Diseases, Department of Molecular and Biomedical Science, Adelaide, Australia (GRID:grid.1010.0) (ISNI:0000 0004 1936 7304)
9 Versiti Blood Center of Wisconsin, Blood Research Institute, Milwaukee, USA (GRID:grid.280427.b) (ISNI:0000 0004 0434 015X); Medical College of Wisconsin, Department of Medicine, Milwaukee, USA (GRID:grid.30760.32) (ISNI:0000 0001 2111 8460)
10 Northwestern University Feinberg School of Medicine, Department of Pathology, Chicago, USA (GRID:grid.16753.36) (ISNI:0000 0001 2299 3507)
11 Wayne State University School of Medicine, Department of Pathology, Detroit, USA (GRID:grid.254444.7) (ISNI:0000 0001 1456 7807)